Skip to content

Market Newsdesk

Latest Business News in Real Time

Posted on November 12, 2020 9:37 am by Newsdesk

SFL – Third Quarter 2020 Results Presentation

Please find enclosed the presentation of the preliminary third quarter results to be held November 12, 2020, in the link below.

Attachment

  • SFL – Third Quarter 2020 Results Presentation

Post navigation

Previous PostPrevious Uncommon Giving Adds Workplace Generosity for Corporate Employee Engagement
Next PostNext InvestorBrandNetwork Named as Official Media Partner for the Benzinga Global Small Cap Conference, InvestorWire to Serve as Official Newswire

Recent Articles

  • ImmunityBio, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – IBRX March 29, 2026 7:33 am
  • MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting March 28, 2026 3:11 pm
  • Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity March 28, 2026 3:09 pm
  • New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis March 28, 2026 3:07 pm
  • Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting March 28, 2026 3:05 pm
  • Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care March 28, 2026 3:03 pm
  • Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session March 28, 2026 2:48 pm
  • Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis March 28, 2026 1:33 pm
  • Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting March 28, 2026 11:05 am
  • Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting March 28, 2026 11:03 am
Proudly powered by WordPress